134 related articles for article (PubMed ID: 17153510)
21. Effects of duloxetine and WAY100635 on pudendal inhibition of bladder overactivity in cats.
Reese J; Xiao Z; Schwen Z; Matsuta Y; Shen B; Wang J; Roppolo JR; de Groat WC; Tai C
J Pharmacol Exp Ther; 2014 Jun; 349(3):402-7. PubMed ID: 24667547
[TBL] [Abstract][Full Text] [Related]
22. Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats.
Kitta T; Miyazato M; Chancellor MB; de Groat WC; Nonomura K; Yoshimura N
J Urol; 2010 Aug; 184(2):762-8. PubMed ID: 20639053
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model.
Angulo J; Cuevas P; Cuevas B; Gupta S; Sáenz de Tejada I
J Pharmacol Exp Ther; 2004 Jul; 310(1):141-9. PubMed ID: 15034084
[TBL] [Abstract][Full Text] [Related]
24. A bladder-cooling reflex in the anaesthetised guinea-pig: a model of the positive clinical ice-water test.
Gardiner JC; McMurray G; Westbrook S
J Pharmacol Toxicol Methods; 2007; 55(2):184-92. PubMed ID: 16905339
[TBL] [Abstract][Full Text] [Related]
25. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
[TBL] [Abstract][Full Text] [Related]
26. Duloxetine: in stress urinary incontinence.
McCormack PL; Keating GM
Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
[TBL] [Abstract][Full Text] [Related]
27. Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.
Miyazato M; Kaiho Y; Kamo I; Chancellor MB; Sugaya K; de Groat WC; Yoshimura N
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F264-71. PubMed ID: 18480175
[TBL] [Abstract][Full Text] [Related]
28. What do we know about duloxetine's mode of action? Evidence from animals to humans.
Schuessler B
BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
[TBL] [Abstract][Full Text] [Related]
29. Recording the evoked canine detrusor electromyogram.
Scheepe JR; Bross S; Schumacher S; Braun P; Weiss J; Alken P; Jünemann KP
Neurourol Urodyn; 1999; 18(6):687-95. PubMed ID: 10529717
[TBL] [Abstract][Full Text] [Related]
30. Clinical import of serotonin activity in the bladder and urethra.
Vaidyanathan S; Rao MS; Chary KS; Swamy RP
J Urol; 1981 Jan; 125(1):42-3. PubMed ID: 7463581
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.
Thase ME; Tran PV; Wiltse C; Pangallo BA; Mallinckrodt C; Detke MJ
J Clin Psychopharmacol; 2005 Apr; 25(2):132-40. PubMed ID: 15738744
[TBL] [Abstract][Full Text] [Related]
32. Duloxetine: a new approach for treating stress urinary incontinence.
Moore K
Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
[TBL] [Abstract][Full Text] [Related]
33. Acute and long-term administration of citalopram desensitizes alpha2-adrenoceptors in the rat vas deferens.
Grandoso L; García L; Pineda J; Ugedo L
J Pharm Pharmacol; 2006 Mar; 58(3):367-73. PubMed ID: 16536904
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in vivo study.
Kim SC; Seo KK; Han JH; Lee MY
J Urol; 2000 Jun; 163(6):1988-91. PubMed ID: 10799244
[TBL] [Abstract][Full Text] [Related]
35. Effects of LY215490, a competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonist, on the micturition reflex in the rat.
Yoshiyama M; Roppolo JR; de Groat WC
J Pharmacol Exp Ther; 1997 Feb; 280(2):894-904. PubMed ID: 9023304
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the role of the serotoninergic system in the control of human seminal vesicle smooth muscle-an in vitro approach.
Birowo P; Uckert S; Kedia GT; Scheller F; Meyer M; Taher A; Rahardjo D; Jonas U; Kuczyk MA
J Sex Med; 2009 Oct; 6(10):2672-9. PubMed ID: 19686430
[TBL] [Abstract][Full Text] [Related]
37. Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.
Chappell JC; Eisenhofer G; Owens MJ; Haber H; Lachno DR; Dean RA; Knadler MP; Nemeroff CB; Mitchell MI; Detke MJ; Iyengar S; Pangallo B; Lobo ED
J Clin Psychopharmacol; 2014 Feb; 34(1):9-16. PubMed ID: 24346757
[TBL] [Abstract][Full Text] [Related]
38. Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity.
Chuang YC; Chancellor MB; Seki S; Yoshimura N; Tyagi P; Huang L; Lavelle JP; De Groat WC; Fraser MO
Urology; 2003 Mar; 61(3):664-70. PubMed ID: 12639680
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.
Jones CK; Peters SC; Shannon HE
J Pharmacol Exp Ther; 2005 Feb; 312(2):726-32. PubMed ID: 15494550
[TBL] [Abstract][Full Text] [Related]
40. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
Kasamo K; Blier P; De Montigny C
J Pharmacol Exp Ther; 1996 Apr; 277(1):278-86. PubMed ID: 8613930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
